Gastroenterology

Diseases, Conditions, Syndromes

AGA recommends change in testing protocol for cirrhosis patients

Patients with cirrhosis, or permanent liver damage, are at higher risk for coagulation disorders, which impact your body's ability to control blood clotting. This puts cirrhosis patients at increased risk of morbidity and ...

Oncology & Cancer

Benefits of gene-specific approaches to colon cancer surveillance

Regenstrief Research Scientist Jennifer K. Maratt, M.D., M.S., co-authored a commentary in Gastroenterology about the benefits of gene-specific surveillance colonoscopy strategies for Lynch Syndrome, an inherited syndrome ...

Oncology & Cancer

How chronic intestinal inflammation can cause cancer

Chronic inflammatory bowel disease (IBD) are inflammations of the gastrointestinal tract which flare up in phases and are accompanied by bloody bowel movements, diarrhea and severe impairment of the quality of life. IBD patients ...

Oncology & Cancer

Uncovering how injury to the pancreas impacts cancer formation

Research from scientists at the Vanderbilt University School of Medicine Basic Sciences and the Salk Institute for Biological Studies shows that acinar cells in the pancreas form new cell types to mitigate injury but are ...

Immunology

Immunodeficiency affects intestinal microbiome

In the largest study of intestinal bacterial composition (also called the intestinal microbiome) to date in persons with the immunodeficiency selective IgA deficiency, researchers at DTU Bioengineering have ascertained that ...

Gastroenterology

Bacteria underlie success of fecal microbiota transplants

The effectiveness of fecal microbiota transplantation (FMT) in treating ulcerative colitis depends on a small set of beneficial bacterial strains, suggests a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Gastroenterology

Prevalence of primary sclerosing cholangitis in IBD examined

(HealthDay)—The global prevalence of primary sclerosing cholangitis (PSC) ranges from 0.96 percent in Crohn disease (CD) to 2.47 percent in ulcerative colitis (UC), according to a review published online Aug. 19 in Gastroenterology.

page 10 from 40